Orchid Pharma quarterly resultsNext results date, and the last two years

Next results · July–September 2026
Not announced yet

Orchid Pharma hasn't told NSE when its board will meet. Listed companies must declare their July–September 2026 results by 14 November.

Get an email before Orchid Pharma reports

Up to three days before, and on the day with the results as soon as they're filed.

Not investment advice

Dates come from Orchid Pharma's filings on NSE and can change until the meeting happens. This is information, not a recommendation to buy or sell. Stockport is not a SEBI-registered investment adviser.

Source: NSE · updated 23 Oct, 09:05 IST

Over the last 8 quarters on file, Orchid Pharma published its results 42 to 56 days after each quarter ended. Its July–September results came on 11 November 2025 and 11 November 2024.

Past results dates

NSE ORCHPHARMA
QuarterPeriodResults filedDays after quarter endResults
Q2 FY27Jul–Sep 2026Not announced yet
Q1 FY27Apr–Jun 2026Fri 14 Aug 202645Read
Q4 FY26Jan–Mar 2026Mon 25 May 202655Read
Q3 FY26Oct–Dec 2025Wed 11 Feb 202642Read
Q2 FY26Jul–Sep 2025Tue 11 Nov 202542Read
Q1 FY26Apr–Jun 2025Tue 12 Aug 202543Read
Q4 FY25Jan–Mar 2025Mon 26 May 202556Read
Q3 FY25Oct–Dec 2024Wed 12 Feb 202543Read
Q2 FY25Jul–Sep 2024Mon 11 Nov 202442Read

Never miss a results day on your stocks

Stockport is an investment research journal for serious investors. It makes your thesis actionable by reading out claims from your raw notes and keeping score against them.

Try Stockport free
Read before results day

Questions about Orchid Pharma's results

When will Orchid Pharma announce its July–September 2026 results?

Orchid Pharma has not announced the date yet. Listed companies must declare their July–September 2026 results by 14 November; this page shows the date as soon as the company files it with NSE.

Where can I read Orchid Pharma's results?

Once the company files them with NSE, a link appears on this page next to the quarter. The last eight quarters' filings are linked in the table above.